Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ISRCTN |
Last refreshed on:
|
17 October 2016 |
Main ID: |
ISRCTN53264564 |
Date of registration:
|
20/01/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Cervical Swede score screening by colposcope and the Gynocular
|
Scientific title:
|
The Bangladesh Swede score Gynocular clinical trial |
Date of first enrolment:
|
01/06/2012 |
Target sample size:
|
540 |
Recruitment status: |
Completed |
URL:
|
http://isrctn.com/ISRCTN53264564 |
Study type:
|
Interventional |
Study design:
|
Crossover randomized clinical trial (Screening)
|
Phase:
|
|
|
Countries of recruitment
|
Bangladesh
| | | | | | | |
Contacts
|
Name:
|
Ashrafun
Nessa |
Address:
|
Department of Obstetrics and Gynecology
Bangabandhu Sheikh Mujib Medical University Hospital (BSMMU)
Shabag
1000
Dhaka
Bangladesh |
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Women positive for acetic acid (VIA) at opportunistic screening by trained family welfare visitors, senior staff nurses and doctors in the Dhaka region, Bangladesh, referred for colposcopy at the Colposcopy Clinic of Bangabandhu Sheikh Mujib Medical University (BSMMU). A women is considered to be VIA positive when a trained doctor or nurse noticed sharp, distinct, well defined, dense acetowhite areas on the cervix, with or without raised margins, close to the squamocolumnar junction (SCJ) in the transformation zone 6-9, 15. 2. Women signing an informed consent to participate in the study after receiving oral and written information from a social worker 3. Ability to understand written and oral information
Exclusion criteria: 1. Ongoing vaginal bleeding 2. Any previous gynecological examinations for at least one week before 3. Pregnancy
Age minimum:
Age maximum:
Gender:
Female
|
Health Condition(s) or Problem(s) studied
|
Cervical screening
Colposcopy
Swede score Urological and Genital Diseases
|
Intervention(s)
|
Patients were randomized to two groups: Group 1 were examined with the hand-held colposcope, the Gynocular Group 2 were examined with a stationary colposcope Participants were then crossed over. Those randomized to Group 1 were examined with the stationary colposcope and Group 2 were examined using the Gynocular. Women who had a positive cytology or cervical biopsy with high-grade cervical dysplasia were offered treatment at BSMMU.
|
Primary Outcome(s)
|
Compare if a hand-held colposcope, the Gynocular, could detect cervical lesions equal to a stationary colposcope
|
Secondary Outcome(s)
|
To evaluate the performance of Swede score to detect cervical lesions in VIA-positive women, and detection rates of HPV
|
Source(s) of Monetary Support
|
Gynius AB (Sweden), H&M Conscious Foundation (Sweden)
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|